首页 | 本学科首页   官方微博 | 高级检索  
检索        

肿瘤化学治疗药物的研究——9-胺基吖啶类化合物的合成
引用本文:张葆珣,谢克勤,刘纪云.肿瘤化学治疗药物的研究——9-胺基吖啶类化合物的合成[J].药学学报,1980,15(1):40-45.
作者姓名:张葆珣  谢克勤  刘纪云
作者单位:天津药物研究所 (张葆珣,谢克勤),天津药物研究所(刘纪云)
摘    要:1942年Badger发现若干甲基苯骈吖啶化合物能抑制Walker 256癌肉瘤生长;Lewis和Goland实验证明了包括阿的平(Atebrin)在内的一些氨基取代的吖啶衍生物,对移植性小鼠肉瘤或乳癌生长具有抑制作用。由此胺基吖啶类化合物的抗肿瘤实验研究有了发展。1954年发现9-(3′-一二甲胺基丙胺基)吖啶抑制小鼠S_(180)作用后,波兰Ledóchowski等合成了大

收稿时间:1979-02-14

STUDY ON CANCER CHEMOTHERAPY——SYNTHESIS OF 9-AMINOACRIDINE COMPOUNDS
Zhang Baoxun,Xie Keqin and Liu Jiyun.STUDY ON CANCER CHEMOTHERAPY——SYNTHESIS OF 9-AMINOACRIDINE COMPOUNDS[J].Acta Pharmaceutica Sinica,1980,15(1):40-45.
Authors:Zhang Baoxun  Xie Keqin and Liu Jiyun
Abstract:As certain compounds of acridine group were known to have anti-tumor effect in animal experiments and have been studied extensively, a number of 9-aminoacridine derivatives were prepared in this laboratory. The synthesis were carried out by direct condensation of 9-chloroacridine with pertinent amines in organic solvent, Results of animal screening revealed that compound 9-(p-methylanilino)-acridine was effective against mouse leukemia 615, Sarcoma 180, liver carcinoma (solid), lympho-sarcoma and other tumors when given orally. The compound had been recommended for clinical trial in 1976.
Keywords:
本文献已被 CNKI 等数据库收录!
点击此处可从《药学学报》浏览原始摘要信息
点击此处可从《药学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号